ClinConnect ClinConnect Logo
Search / Trial NCT05967468

Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder

Launched by BAYLOR COLLEGE OF MEDICINE · Jul 28, 2023

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Obsessive Compulsive Disorder Anxiety Cognitive Behavioral Therapy Children

ClinConnect Summary

This clinical trial is studying two different types of treatments for children aged 7 to 13 who have anxiety or obsessive-compulsive disorder (OCD). The goal is to find out which method is more effective and how they work. One treatment involves family-based therapy delivered through telehealth, while the other is a Relaxation and Mentorship Training (RMT) program that includes breathing exercises with a therapist. This study is important because many children struggle with anxiety and OCD, and access to traditional therapy can be limited.

To participate in this trial, children must have significant anxiety or OCD symptoms and a parent or guardian who is willing to be involved in the treatment process. They also need to live in Texas and be able to read and understand English. Participants can expect to engage in therapy sessions that aim to help manage their anxiety or OCD in a supportive family environment. It’s also vital to note that certain conditions, like severe mood disorders or substance dependence, may exclude children from the study. Overall, this trial offers a potential pathway to effective treatment for young people facing these challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The child is between the ages of 7 to 13 years inclusion at enrollment
  • The child has clinically significant symptoms of anxiety and/or OCD, as indicated by a score of 12 or higher on the Pediatric Anxiety Rating Scale (PARS).
  • The child is appropriate for anxiety-focused treatment (e.g., anxiety is the primary or co-primary problem as diagnosed using the Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI-KID).
  • One parent/guardian is able and willing to participate in assessment and treatment (e.g., has sufficient English fluency, the decisional capacity to participate, and can commit to treatment duration).
  • The participating parent/guardian lives with their child at least 50% of the time per self-report.
  • Both parent and child are able to read and understand English.
  • The child has the intellectual and communication skills to engage in CBT, as judged by an experienced supervising clinician.
  • Participants must be in the state of Texas for treatment sessions/assessments.
  • Exclusion Criteria:
  • the child has a diagnosis of child lifetime bipolar disorder, drug or alcohol dependence, psychotic disorder, or conduct disorder.
  • the child has severe, current suicidal/homicidal ideation and/or self-injury requiring medical intervention (referrals will be made for appropriate clinical intervention).
  • the child is receiving concurrent therapy for anxiety.
  • New Treatments: Initiation of an antidepressant within 12 weeks before study enrollment OR 6 weeks for an antipsychotic, benzodiazepine, or attention deficit hyperactivity disorder (ADHD) medication before study enrollment. Established Treatment changes: Any change in established psychotropic medication (e.g., antidepressants, anxiolytics, antipsychotic) within 4 weeks before study enrollment. Any medications must remain stable during treatment; downward adjustments due to side effects may be acceptable.

About Baylor College Of Medicine

Baylor College of Medicine is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. Located in Houston, Texas, it is renowned for its commitment to excellence in medical education and translational research, fostering collaborations that bridge laboratory discoveries with clinical application. As a clinical trial sponsor, Baylor College of Medicine leverages its robust infrastructure, interdisciplinary expertise, and access to diverse patient populations to conduct cutting-edge clinical studies aimed at improving patient outcomes and enhancing therapeutic approaches across a wide range of medical conditions.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported